105 related articles for article (PubMed ID: 10650672)
1. [IgA nephropathy and intrahepatic percutaneous portosystemic shunt].
Blanco Sampascual S; de las Heras Niño B; Marcé Landeta L; Orive Cura V
Gastroenterol Hepatol; 1999 Dec; 22(10):535-6. PubMed ID: 10650672
[No Abstract] [Full Text] [Related]
2. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals.
Herrero JI; Bilbao JI; Diaz ML; Alegre F; Inarrairaegui M; Pardo F; Quiroga J
Liver Transpl; 2009 Jan; 15(1):111-4. PubMed ID: 19109845
[No Abstract] [Full Text] [Related]
3. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
4. Studies of IgA nephropathy in renal transplantation.
Suganuma T; Morozumi K; Satoh K; Yosida A; Fujinami T; Uchida K; Yamada N; Orihara A; Tanaka Y; Shinmura I
Transplant Proc; 1989 Feb; 21(1 Pt 2):2123-7. PubMed ID: 2652686
[No Abstract] [Full Text] [Related]
5. [Hemolysis associated with intrahepatic percutaneous portosystemic shunt].
Pérez Roldan F; Rodríguez Laíz JM; Casado M; Bañares R; Lago M; Clemente G; Echenagusía A; Camúñez F; Cos E
Gastroenterol Hepatol; 1995 Apr; 18(4):169-71. PubMed ID: 16541562
[TBL] [Abstract][Full Text] [Related]
6. Resolution of cirrhotic glomerulonephritis following successful liver transplantation.
Ghabra N; Piraino B; Greenberg A; Banner B
Clin Nephrol; 1991 Jan; 35(1):6-9. PubMed ID: 2007299
[TBL] [Abstract][Full Text] [Related]
7. [Transjugular intrahepatic portosystemic shunt before hepatic surgery in a patient with cirrhosis and portal hypertension: case report].
Chalret Du Rieu M; Carrere N; Bureau C; Lagarde S; Otal P; Pradere B
J Chir (Paris); 2009 Apr; 146(2):191-4. PubMed ID: 19535077
[TBL] [Abstract][Full Text] [Related]
8. Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation.
Orug T; Soonawalla ZF; Tekin K; Olliff SP; Buckels JA; Mayer AD
Br J Surg; 2004 Jun; 91(6):769-73. PubMed ID: 15164449
[TBL] [Abstract][Full Text] [Related]
9. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
Dell'Era A; Grande L; Barros-Schelotto P; Turnes J; Fuster J; Charco R; García-Valdecasas JC; Bosch J; García-Pagán JC
Surgery; 2005 Jun; 137(6):620-5. PubMed ID: 15933628
[TBL] [Abstract][Full Text] [Related]
10. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
11. Influence of a prior porta-systemic shunt on outcome after liver transplantation.
Langnas AN; Marujo WC; Stratta RJ; Donovan JP; Sorrell MF; Rikkers LF; Shaw BW
Am J Gastroenterol; 1992 Jun; 87(6):714-8. PubMed ID: 1590306
[No Abstract] [Full Text] [Related]
12. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
Kavitt RT; Yang VL; Jensen DM
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
[TBL] [Abstract][Full Text] [Related]
13. Portosystemic shunt via the superior mesenteric and right ovarian vein leading to small intestine bleeding in alcoholic liver cirrhosis.
Vamadevan S; Haltmeier T; Groebli Y
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23513021
[No Abstract] [Full Text] [Related]
14. [Treatment of refractory hydrothorax with intrahepatic portosystemic shunt in the course of primary biliary cirrhosis].
Bechade D; Blanc JF; Lescene R; Drouillard J; Oddes B
Gastroenterol Clin Biol; 1998; 22(8-9):743-5. PubMed ID: 9823569
[No Abstract] [Full Text] [Related]
15. Membranoproliferative glomerulonephritis with IgA deposits in patients with alcoholic cirrhosis.
Ferrario G; Palazzi P; Torri Tarelli L; Volpi A; Meroni M; Giordano F; Sessa A
Pathologica; 1986; 78(1056):469-78. PubMed ID: 3615024
[No Abstract] [Full Text] [Related]
16. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center.
Gutierrez-Baños J; Portillo J; Ballestero R; Zubillaga S; Ramos E; Campos J; Hidalgo E
Transplant Proc; 2008 Dec; 40(10):3424-7. PubMed ID: 19100404
[TBL] [Abstract][Full Text] [Related]
17. Vasculitic IgA nephropathy: prognosis and outcome.
Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
[TBL] [Abstract][Full Text] [Related]
18. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
19. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome.
Bachet JB; Condat B; Hagège H; Plessier A; Consigny Y; Belghiti J; Valla D
J Hepatol; 2007 Jan; 46(1):60-8. PubMed ID: 17107735
[TBL] [Abstract][Full Text] [Related]
20. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
Coppo R; Amore A; Chiesa M; Lombardo F; Cirina P; Andrulli S; Passerini P; Conti G; Peruzzi L; Giraudi R; Messina M; Segoloni G; Ponticelli C
Clin Transplant; 2007; 21(6):728-37. PubMed ID: 17988266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
